Cor Van den Bos

9PUBLICATIONS
127CO-AUTHORS
Immunogenetics (incl. genetic immunology)HaematologyHaematological tumoursMedical biochemistry - proteins and peptides (incl. medical proteomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 03, 2024
Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis.

Paul G Kemps, F J Sherida H Woei-A-Jin, Koen D Quint

|Jan 12, 2024
Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms.

Paul G Kemps, Lennart Kester, Marijn A Scheijde-Vermeulen

|Aug 18, 2023
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis.

Aldo A Acosta-Medina, Paul G Kemps, Timo C E Zondag

|Jun 26, 2023
Clinical associations of BRAF and MAP2K1 mutations in pediatric Langerhans cell histiocytosis: When 1 + 1 = 3.

Paul G Kemps, Cor van den Bos, Astrid G S van Halteren

|Mar 11, 2023
Thyroid Profile in the First Three Months after Starting Treatment in Children with Newly Diagnosed Cancer.

Chantal A Lebbink, Cor van den Bos, Miranda P Dierselhuis

|Sep 09, 2022
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.

Paul G Kemps, Timo C E Zondag, Helga B Arnardóttir

Pageof 2

Frequent Collaborators

6 joint publications

Astrid G S van Halteren

6 joint publications

Paul G Kemps

5 joint publications

Robert M Verdijk

4 joint publications

Jan A M van Laar